Page 127 - GPD-3-3
P. 127

Gene & Protein in Disease                                              Hydrogen sulfide ameliorates NAFLD



            and  a  decrease  in  mTOR  phosphorylation  in  mouse   Furthermore, the exploration and validation of innovative
            hepatocytes, as observed through Western blotting analysis.   therapeutic agents hold significant importance.
            Specifically, 100 μM NaHS led to the most significant increase   In  this  study, our  findings  convincingly  demonstrate
            in AMPK phosphorylation, whereas 50 μM NaHS caused   that NaHS, a hydrogen sulfide donor, exerts a profound
            the  most  significant  decrease in  mTOR  phosphorylation   therapeutic effect on NAFLD in mice, effectively
            levels (Figure  6A-C,  Figure R1). Furthermore, we   ameliorating the associated symptoms in both  in vitro
            investigated these phosphorylation changes in animal   and in vivo studies. Based on transcriptome data analysis
            models. In NaHS-treated HFD mice, the phosphorylation   and Western blotting experiments, our findings present
            levels of AMPK and mTOR mirrored the results observed   preliminary evidence  highlighting  the significant  role of
            in cell culture. Specifically, NaHS treatment led to decreased   cellular autophagy activation in mitigating the symptoms
            phosphorylation of AMPK and increased phosphorylation
            of mTOR in comparison to the control group, suggesting   of NAFLD in mice.
            that the AMPK mTOR pathway is inhibited in the liver tissue   Acknowledgments
            of HFD mice. Moreover, the expression of the autophagy
            marker protein LC3BII was significantly elevated following   None.
            both starvation (which stimulates cellular autophagy) and
            prolonged NaHS incubation (Figures 6D and E, Figure R2).   Funding
            Similar  changes  in  LC3BII  expression  were  observed  in   This research was funded by The Key R&D and Promotion
            HFD mice treated with NaHS.                        Projects of Henan Province (232102311139); China

              In  addition,  we  assessed  two  autophagy-associated   Postdoctoral Science Foundation (2021m690095); National
            marker proteins, adipose differentiation-related protein   Innovation and Entrepreneurship Training Program for
            (ADRP) (lipid droplet protein) and p62, in the liver tissues   College Students (202310475169); and Henan University
            of HFD mice following NaHS treatment. Compared to the   Research Laboratory Open Project for Undergraduate
            HFD group, NaHS-treated mice exhibited decreased levels   Students (20233001246 and 20233306208).
            of both p62 and ADRP in their liver tissues. These findings   Conflict of interest
            suggest that NaHS treatment reactivates the AMPK-mTOR
            pathway, leading to increased autophagy and decreased   The authors declare no conflict of interest.
            lipid droplet accumulation. These results are consistent
            with the staining of mouse liver tissue sections and liver   Author contributions
            biochemical assays (Figure R3).                    Conceptualization: Na Chen, Tieshan Teng
            4. Conclusion                                      Investigation: Yuhan Wang
                                                               Methodology: Hanyue Zhuang, Jingjing Li
            NAFLD has emerged as a significant threat to human   Writing – original draft: Hanyue Zhuang, Jiangzhe Si
            health, exerting a substantial burden on both individuals   Writing – review & drafting:  Zewei Yang, Waner Wang,
            and society. This mounting concern is primarily       Zimo Ge
            attributed to the disease’s potential to cause substantial
            occupational limitations and the high costs associated   Ethics approval and consent to participate
            with its treatment. Despite the expansive market for   The study received approval (Approval ID: HUSOM2024-
            therapeutic drugs aimed at addressing NAFLD, research   088) from the Institutional Animal Care and Use
            and development in this field remain fiercely competitive.   Committee (IACUC) at XXX.
            Although numerous drugs are currently undergoing
            clinical  trials,  no  individual  targeted  drug  has  yet   Consent for publication
            obtained regulatory approval for marketing. At present,
            the primary treatment options for NAFLD involve a   Not applicable.
            diverse range of lifestyle interventions recommended   Availability of data
            based  on  mechanistic  research.  In  addition,  there  is
            a  growing  trend  of  repurposing  existing  drugs  with   Data used in this work are available from the corresponding
            established efficacy in enhancing insulin sensitivity,   author upon reasonable request.
            reducing lipid levels, and providing antioxidant benefits.
            Given the present scenario, it becomes crucial to delve   References
            into the mechanisms underlying the development and   1.   Chen Y, Gao WK, Shu YY, Ye J. Mechanisms of ductular
            regression of NAFLD through fundamental experiments.   reaction in non-alcoholic steatohepatitis.  World J


            Volume 3 Issue 3 (2024)                         9                               doi: 10.36922/gpd.3409
   122   123   124   125   126   127   128   129   130   131   132